Tilray Brands

Tilray Brands, Inc. (TLRY) (Q1FY24) – Is TLRY positioned to win in emerging markets

Highlights of the report

Tilray Brands EU GMP-certified cultivation and manufacturing facility in Portugal and Germany offers a strategic advantage in these medical cannabis markets compared to peers.

CrispIdea equity reports provide valuable insights to investors who may be individuals and organizations involved in the world of finance and investment like private equity houses, broking firms, hedge funds, investment advisory firms, mutual funds, banks and corporations. This research report is useful for M&A, business & investment analysis to all students and researchers also.


CrispIdea equity reports include basic financials, strategic analysis, competitive landscape assessments, stock performance, stock analysis and future growth potential evaluation. CrispIdea utilizes a proprietary blend of fundamental and technical analysis, offering a unique perspective. Reports present clear investment recommendations (“BUY,” “HOLD,” or “SELL”).


Our established reputation and track record advocates that our research carries weight within the investment community. Do connect with us, if you are looking for customized research, equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.

Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business.

Tilray Brands Revenue has increased to $176.9mn in Q1FY24 compared to $153.2mn in Q1FY23 and the COGS has also increased to $132.8mn which is 75% of the revenue in Q1FY24 from $104.6mn which was 68% of the revenue in Q1FY23

Over the past 3 months Tilray Brands stock price decreased by (39.5%) from $3.31 on 11th Sep 2023 to $1.18 on 29th Nov 2023



– Enterprise Value
– CrispIdea Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– Key Metrics
– M&A Deals

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance


Stock Price Performance

Crispidea Coverage

Report details

Tilray Brands, Inc. (TLRY) (Q1FY24) – Is TLRY positioned to win in emerging markets



Company Reports

Sector Reports